Newronika Announces First Participant Implanted in ADVENT Pivotal Study

Trial StartAdaptive Deep Brain StimulationPositive

AI Analysis

Summary

Newronika announced the first participant implantation in its ADVENT pivotal study comparing adaptive and conventional deep brain stimulation for Parkinson's disease treatment.

Clinical Trial Data

Phase

pivotal

Patients

Outcome Details

First participant implanted in ADVENT pivotal study

Importance:5/10

Sentiment:

0.60

deep brain stimulationParkinson's diseasemedical devicepivotal trialadaptive therapy

Related Companies

$ISCO $ADPT $MDCE $BNN.DE $TRAX

Read the original article

Published by PR Newswire Biotech on September 30, 2026 9:01 AM

Read Original